Estradiol, gonadotropins, and tumor markers in ovarian cyst fluid

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 5, 1997, Pages 478-483

  Reimer, Toralf ^a   Gerber, Bernd ^a,b   Kunkel, Siegfried ^a   Luettich, Karsta ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Cyst fluid analysis; Estradiol; Gonadotropins; Ovarian cyst; Tumor marker

Indexed keywords

CA 125 ANTIGEN; CA 72-4 ANTIGEN; CANCER ASSOCIATED SERUM ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CYST FLUID; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HISTOLOGY; HUMAN; IMMUNORADIOMETRIC ASSAY; OVARY CANCER; OVARY CYST; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0030949014     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349709047832     Document Type: Article

References (24)

1. Franchi M, Beretta P, Ghezzi F, Zanaboni F, Goddi A, Salvatore S. Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography. Acta Obstet Gynecol Scand 1995; 74: 734-9.
2. Gerber B, Gustmann G, Külz T, Rohde E, Beust M, Sudik R. Histologie und Zytologie laparoskopisch operierter 'simpler' Ovarialzysten. [Histology and cytology of laparoscopically operated 'simple' ovarian cysts.] (In German with English abstract.) Geburtsh Frauenheilk 1995; 55: 369-73.
3. Moran O, Menczer J, Ben-Baruch G, Lipitz S, Goor E. Cytologic examination of ovarian cyst fluid for the distinction between benign and malignant tumors. Obstet Gynecol 1993; 82: 444-6.
4. Tekay A, Jouppila P. Controversies in assessment of ovarian tumors with transvaginal color Doppler ultrasound. Acta Obstet Gynecol Scand 1996; 75: 316-29.
5. Zanetta G, Vergani P, Lissoni A. Color Doppler ultrasound in the preoperative assessment of adnexal masses. Acta Obstet Gynecol Scand 1994; 73: 637-41.
6. De Crespigny LC, Robinson HP, Davoren RAM, Fortune D. The 'simple' ovarian cyst: Aspirate or operate? Br J Obstet Gynaecol 1989; 96: 1035-9.
7. Ammann M, Hänggi W, Baumann U, Keller PJ. Differentialdiagnostik zystischer Ovarialtumoren durch Bestimmung von Östradiol im Zystenpunktat. [Differential diagnosis of cystic ovarian tumours by determination of oestradiol in cystic aspirate.] (In German with English abstract.) Geburtsh Frauenheilk 1991; 51: 481-3.
8. Halila H, Huhtala ML, Haglund C, Nordling S, Stenman UH. Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA. Br J Cancer 1987; 56: 153-6.
9. Pinto MM, Bernstein HH, Brogan DA. Measurement of CA-125, carcinoembryonic antigen and alphafetoprotein in ovarian cyst fluids: Diagnostic adjunct to cytology. Acta Cytol 1988; 32: 747.
10. Devine PL, McGuckin MA, Ramm LE, Ward BG, Pee D, Long S. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. Cancer 1993; 72: 2007-15.
11. Oram DH, Jeyarajah AR. The role of ultrasound and tumour markers in the early detection of ovarian cancer. Br J Obstet Gynaecol 1994; 101: 939-45.
12. Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis. Gynecol Oncol 1992; 44: 147-54.
13. Menczer J, Ben-Baruch G, Moran O, Lipitz S. Cyst fluid CA 125 levels in ovarian epithelial neoplasms. Obstet Gynecol 1993; 81: 25-8.
14. Bischof P What do we know about the origin of CA 125? Eur J Obstet Gynecol Reprod Biol 1993; 49: 93-8.
15. Pinto MM, Greenebaum E, Simsir A, Kleinman GM, Portnoy LM, Garfinkel R. Benign ovarian cyst aspiration: tumor markers vs. cytologist' expertise. Acta Cytol 1995; 39: 1022.
16. Vercellini P, Oldani S, Felicetta I, Bramante T, Rognoni MT, Crosignani PG. The value of cyst puncture in the differential diagnosis of benign ovarian tumours. Hum Reprod 1995; 10: 1465-9.
17. McGuckin MA, Ramm LE, Joy GJ, Free KE, Ward BG. Preoperative discrimination, non-ovarian gynecological malignancy and benign adnexal masses using serum levels of CA 125 and the polymorphic epithelial mucin antigens CASA, OSA and MSA. Int J Gynecol Cancer 1992; 2: 119-28.
18. Mulvany N, Ostor A, Teng G. Evaluation of estradiol in aspirated ovarian cystic lesions. Acta Cytol 1995; 39: 663-8.
19. Gaetje R, Popp LW. Is differentiation of benign and malignant cystic adnexal masses possible by evaluation of cysts fluids with respect to color, cytology, steroid hormones, and tumor markers? Acta Obstet Gynecol Scand 1994; 73: 502-7.
20. 2 content in ovarian tumors. Acta Cytol 1981; 25: 400-6.
21. Kreuzer GF, Paradowski T, Wurche KD, Flenker H. Neoplastic or nonneoplastic ovarian cyst? The role of cytology. Acta Cytol 1995; 39: 882-6.
22. Berek JS, Martinez-Maza O, Hamilton T, Tropé C, Kaern J, Baak J et al. Molecular and biological in the pathogenesis of ovarian cancer. Ann Oncol 1993; 4: 3-16.
23. Janson PO. Significance of endocrine factors in the development of ovarian epithelial carcinoma. Acta Obstet Gynecol Scand 1996; 75 Suppl 162: 7-8.
24. Kullander S, Rausing A, Schally AV. LHRH agonist treatment in ovarian cancer. In: Klijn JGM, Paridaens R, Foekens JA, eds. Hormonal manipulation of cancer: Peptides, growth factors, and new (anti) steroidal agents. New York: Raven Press, 1987: 353-6.